You are here

  • Home
  • Archive
  • Volume 73, Issue 6
  • A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies

Article info

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies

Authors

  • Sandra Garcês Department of Immunology, Instituto Gulbenkian de Ciência, Oeiras, Portugal Gulbenkian Programme for Advanced Medical Education, Lisbon, Portugal Rheumatology Department, Hospital Garcia de Orta, Almada, Portugal PubMed articlesGoogle scholar articles
  • Marília Antunes Faculty of Sciences, Department of Statistics and Operations Research, University of Lisbon, Lisbon, Portugal Center of Statistics and Applications, Lisbon, Portugal PubMed articlesGoogle scholar articles
  • Elizabeth Benito-Garcia Department of Epidemiology, BioEPI, Clinical and Translational Research Center, Oeiras, Portugal F. Hoffmann-La Roche, Pharmaceuticals Division, Global Pricing and Market Access, Modeling, Outcomes Research, Statistics and Epidemiology (MORSE), The Roche Health Technology Assessment Group, Basel, Switzerland PubMed articlesGoogle scholar articles
  • José Canas da Silva Rheumatology Department, Hospital Garcia de Orta, Almada, Portugal PubMed articlesGoogle scholar articles
  • Lucien Aarden Immunopathology Department, Sanquin Research Institute, Amsterdam, Netherlands PubMed articlesGoogle scholar articles
  • Jocelyne Demengeot Department of Immunology, Instituto Gulbenkian de Ciência, Oeiras, Portugal PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sandra Pinheiro Garcês da Gama, Rheumatology Department, Hospital Garcia de Orta, Av. Torrado da Silva, Almada 2801-951, Portugal; sandragarcesmail{at}gmail.com, sgama{at}igc.gulbenkian.pt
View Full Text

Citation

Garcês S, Antunes M, Benito-Garcia E, et al
A preliminary algorithm introducing immunogenicity assessment in the management of patients with RA receiving tumour necrosis factor inhibitor therapies
Annals of the Rheumatic Diseases 2014;73:1138-1143.

Publication history

  • Accepted April 14, 2013
  • First published May 11, 2013.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions